Brief: ADC Therapeutics SA - Selling Shareholders May Offer 14.7 Million Common Shares - SEC Filing
10/11/2025 22:29
Nov 11 (Reuters) - ADC Therapeutics SA ADCT.N: ADC THERAPEUTICS SA - SELLING SHAREHOLDERS MAY OFFER 14.7 MILLION COMMON SHARES - SEC FILING Source text: [ID:n0000950103-25-014521] Further company coverage: ADCT.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ADC Therapeutics SA
See all newsADC Therapeutics plunges after patient deaths in blood cancer drug trial
ADC Therapeutics falls on higher rates of serious side-effects in cancer trial
Switzerland's ADC Therapeutics beats Q1 revenue estimates
Switzerland's ADC Therapeutics posts smaller‑than‑expected Q4 net loss on lower R&D spend
Brief: ADC Therapeutics Q4 Income From Operations USD -17.919 Million Vs. IBES Estimate USD -30.1 Million